Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
POLO试验的总生存期结果:一项针对携带生殖系BRCA突变的转移性胰腺癌患者,比较奥拉帕尼维持治疗与安慰剂的III期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01604
Kindler, Hedy L; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla, Teresa; Hall, Michael J; Park, Joon Oh; Hochhauser, Daniel; Arnold, Dirk; Oh, Do-Youn; Reinacher-Schick, Anke; Tortora, Giampaolo; Algül, Hana; O'Reilly, Eileen M; Bordia, Sonal; McGuinness, David; Cui, Karen; Locker, Gershon Y; Golan, Talia